bepmed |

2003194802
l 2003
US

1521. Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells

Abstract

There is provided a simplified and inexpensive method for the in-vitro identification, isolation and culture of human vasculogenic progenitor cells. The method and the progenitor...

13:58 / cells / methods

3006613
l 2003
WO

1522. METHODS FOR EX VIVO PROPAGATION OF SOMATIC STEM CELLS

Abstract

The present invention is directed to methods for readily propagating somatic tissue stem cells ex vivo . The methods comprise enhancing guanine nucleotide (GNP) biosynthesis,...

13:58 / cells / methods

2218114
l 2003
RU

1523. INSTRUMENT FOR PERFORMING OSTEOTOMY OF MAXILLA

Abstract

FIELD: medical engineering. SUBSTANCE: device has handle and working part manufactured as rod. The device is manufactured from titanium nickelide possessing heating memory properties and...

13:58 / rest

2217187
l 2003
RU

1524. DEVICE FOR DETERMINING BIOLOGICAL TISSUE ABSORPTION COEFFICIENT FOR INCIDENT LASER RADIATION

Abstract

FIELD: medical engineering. SUBSTANCE: device has photometric cavity provided with inlet aperture and main and auxiliary outlet apertures. The main outlet aperture enabling one to...

13:58 / methods / system

2003082808
l 2003
US

1525. Composite biodegradable polymer scaffold

Abstract

A polymer scaffold is provided comprising an extensively interconnected macroporous network. The polymer scaffold embodies macropores having a diameter in a range of 0.5-3.5 mm,...

13:58 / methods / Scaffolds

2003064089
l 2003
US

1526. Regenerated cellulose and oxidized cellulose membranes as potential biodegradable platforms for drug delivery and tissue engineering

Abstract

The present invention describes the use of regenerated celluloses (RC) and (ORC) oxidized regenerated celluloses in the manufacture of scaffolds for drug delivery and tissue...

13:58 / methods / Scaffolds

3002173
l 2003
WO

1527. PROCESS AND APPARATUS FOR UTILIZATION OF IN VIVO EXTRACTED PLASMA WITH TISSUE ENGINEERING DEVICES, BIOREACTORS, ARTIFICIAL ORGANS, AND CELL THERAPY APPLICATIONS

Abstract

The present invention is directed to a method of treating cells, tissues or organs using in vivo plasma separation by implanting a plasma separation filter...

13:58 / cells / organ

2003215483
l 2003
US

1528. Medical materials and porous scaffolds for tissue engineering made from the biodegradable glycolide/epsilon-caprolactone copolymer

Abstract

Disclosed is a biocompatible medical material and porous scaffold for use in tissue engineering, made from a biodegradable glycolide/epsilon-caprolactone copolymer. The medical material and porous...

13:58 / Biomaterial / Scaffolds

3097107
l 2003
WO

1529. CONTROLLABLY DEGRADABLE POLYMERIC BIOMOLECULE OR DRUG CARRIER AND METHOD OF SYNTHESIZING SAID CARRIER

Abstract

The present invention provides a controllably degradable cationic polymer for delivery of biomolecules (nucleic acids, peptides, etc.), drugs, molecules used in medical imaging applications, sensitizing...

13:58 / methods / Scaffolds

3099230
l 2003
WO

1530. ELECTROPROCESSED COLLAGEN AND TISSUE ENGINEERING

Abstract

The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming...

13:58 / cells / methods

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract